CVS Health Co. (NYSE:CVS) Shares Purchased by Bristlecone Advisors LLC

Bristlecone Advisors LLC increased its position in shares of CVS Health Co. (NYSE:CVS) by 58.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 10,682 shares of the pharmacy operator’s stock after acquiring an additional 3,939 shares during the quarter. Bristlecone Advisors LLC’s holdings in CVS Health were worth $843,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Live Oak Investment Partners purchased a new stake in CVS Health in the 4th quarter valued at about $25,000. Atticus Wealth Management LLC increased its stake in CVS Health by 149.0% during the fourth quarter. Atticus Wealth Management LLC now owns 366 shares of the pharmacy operator’s stock worth $29,000 after purchasing an additional 219 shares during the period. Cornerstone Planning Group LLC increased its stake in CVS Health by 111.5% during the third quarter. Cornerstone Planning Group LLC now owns 461 shares of the pharmacy operator’s stock worth $32,000 after purchasing an additional 243 shares during the period. PCA Investment Advisory Services Inc. purchased a new stake in CVS Health during the second quarter worth about $37,000. Finally, ZRC Wealth Management LLC increased its stake in CVS Health by 400.0% during the fourth quarter. ZRC Wealth Management LLC now owns 500 shares of the pharmacy operator’s stock worth $39,000 after purchasing an additional 400 shares during the period. Institutional investors and hedge funds own 80.66% of the company’s stock.

Insiders Place Their Bets

In other CVS Health news, EVP Prem S. Shah sold 29,473 shares of the stock in a transaction on Friday, February 16th. The stock was sold at an average price of $76.95, for a total value of $2,267,947.35. Following the completion of the transaction, the executive vice president now owns 39,765 shares in the company, valued at $3,059,916.75. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. 0.25% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

A number of analysts have issued reports on CVS shares. SVB Leerink started coverage on shares of CVS Health in a research note on Monday, February 26th. They set an “outperform” rating and a $88.00 price target on the stock. Barclays started coverage on shares of CVS Health in a research note on Wednesday, March 6th. They set an “equal weight” rating and a $78.00 price target on the stock. HSBC started coverage on shares of CVS Health in a research note on Friday, December 22nd. They set a “buy” rating and a $94.00 price target on the stock. Leerink Partnrs restated an “outperform” rating on shares of CVS Health in a research note on Monday, February 26th. Finally, TD Cowen cut their target price on shares of CVS Health from $102.00 to $99.00 and set an “outperform” rating on the stock in a research note on Monday, December 11th. Four equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. Based on data from MarketBeat.com, CVS Health has an average rating of “Moderate Buy” and an average price target of $89.44.

CVS Health Stock Performance

Shares of CVS opened at $74.58 on Monday. The company has a quick ratio of 0.63, a current ratio of 0.86 and a debt-to-equity ratio of 0.77. The stock has a 50 day moving average price of $76.08 and a 200 day moving average price of $73.78. CVS Health Co. has a 52-week low of $64.41 and a 52-week high of $83.25. The company has a market capitalization of $93.86 billion, a price-to-earnings ratio of 11.54, a price-to-earnings-growth ratio of 0.99 and a beta of 0.52.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Wednesday, February 7th. The pharmacy operator reported $2.12 earnings per share for the quarter, topping the consensus estimate of $2.01 by $0.11. The firm had revenue of $93.81 billion during the quarter, compared to the consensus estimate of $90.58 billion. CVS Health had a return on equity of 15.25% and a net margin of 2.33%. The company’s revenue for the quarter was up 11.9% on a year-over-year basis. During the same period last year, the company earned $1.99 earnings per share. Research analysts predict that CVS Health Co. will post 8.33 EPS for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 1st. Shareholders of record on Monday, April 22nd will be given a $0.665 dividend. This represents a $2.66 annualized dividend and a yield of 3.57%. The ex-dividend date is Friday, April 19th. CVS Health’s payout ratio is 41.18%.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.